BARRIE, ON , April 3, 2023 /CNW/ - MediPharm Labs Corp . (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", or "MediPharm Labs") and VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO") are pleased to announce the completion of the previously announced plan of arrangement under section 192 of the Canada Business Corporations Act (the "Arrangement"), pursuant to which MediPharm has acquired all of the issued and... Read More

Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreement with MediPharm Labs Inc. whereby MediPharm has agreed to acquire VIVO Cannabis Inc. in an all-equity business combination transaction. Shareholders of... Read More

Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that it has obtained a final court order (the " Final Order ") from the Ontario Superior Court of Justice (Commercial List) approving the previously announced plan of arrangement (the " Arrangement ") with MediPharm Labs Corp. (" MediPharm ") under the Canada Business Corporations Act. As... Read More

Toronto, Ontario--(Newsfile Corp. - March 21, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO") is pleased to announce that, at the special meeting of the shareholders of VIVO (the "Shareholders") held today (the "Meeting"), the Shareholders approved (i) a special resolution (the "Arrangement Resolution") authorizing a plan of arrangement under section 192 of the Canada Business Corporations Act (the... Read More

TORONTO , Feb. 17, 2023 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO ") is pleased to announce the mailing of a joint management information circular of VIVO and MediPharm Labs Corp. (" MediPharm ") dated February 6, 2023 (the " Circular ") and related documents for the special meeting of VIVO shareholders to be held virtually at 11:00 a.m. ( Toronto time) on March 21, 2023 (the " Meeting "). The Meeting is... Read More

Net revenue for Q3 2022 was $6.2 million, a 19% increase from prior quarter International sales reach $2.5 million Beacon Medical continues to be the leading medical cannabis flower brand in Australia The Company entered into a third supplement to the indenture for its debentures to extend their maturity to 2024 Subsequent to the quarter-end, the Company recognized $8.8 million of deferred revenue as Other income as part of... Read More

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO " or the " Company ") is pleased to announce that, further to the Company's news release of September 19, 2022, the Company has entered into a third supplemental debenture indenture dated September 29, 2022 (the " Supplemental Indenture ") with TSX Trust Company (" TSXT ") in respect of its outstanding unsecured convertible debentures in the aggregate principal amount of... Read More

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO " or the " Company ") has entered into an agreement dated September 15, 2022 with the majority beneficial owner of its outstanding unsecured convertible debentures dated February 28, 2018 in the aggregate principal amount of $5,546,808 (collectively, the " Debentures ") to amend the terms of the Debentures (the " Amendments "). " We are pleased to have reached an... Read More

Net revenue for Q2 2022 was $5.2 million Company announced that Canna Farms received a Research Licence from Health Canada in June, 2022 Canadian Launch of Fireside™ Pink Kush and Girl Scout Cookies Full-Spectrum 510 Vapes Australian sales delayed due to new regulatory requirements Company announces cost savings workforce reductions focused on its Hope, BC Canna Farms facility Company continues to grow sales in Germany... Read More

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc., today announced that Canna Farms has received a Research Licence from Health Canada allowing it to possess cannabis for the purpose of... Read More

VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQB: VVCIF ) (" VIVO " or the " Company "), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders held today (the " Meeting "). As announced this morning, at the Meeting, shareholders approved fixing the number of directors at five, and the election of Ray Laflamme, Glen Huber, Shai... Read More

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO " or the " Company "), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc., today announced results from its first study investigating how medical cannabis impacts anxiety and depression outcomes. The... Read More

Net revenue for Q1 2022 was $6.9 million VIVO continues to pursue its international expansion strategy which now represents >50% of cannabis revenue Canadian Launch of Canna Farms Single-strain Oils, Infused Pre-rolls, Top Cola Signature Series and Fireside CBD Canna Bliss 510 Vape Cartridge and 10 pack CBD Chocolates Harvest Medicine study on medical cannabis outcomes in anxiety & depression accepted for publication in... Read More

Net revenue for Q4 2021 was $6.9 million; Net revenue for 2021 was $25 million. In February 2021, closed a $7.2 million equity raise to help fund VIVO's growth In July 2021, the Company elected a new Board of Directors, announced the appointment of Ray Laflamme as CEO and Chairman of the Board and later welcomed the Former President of McCain Foods Canada and CEO of Zenabis Global, and Former CFO of Cronos Group, to the... Read More

VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced a... Read More

VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQX: VVCIF ) (" VIVO " or the " Company ") is pleased to announce the appointment of Shai Altman and Glen Huber to the board of directors of the Company (the " Board "), effective immediately. "I am very pleased to welcome Mr. Altman and Mr. Huber to the Board of Directors," said Ray Laflamme, Chairman of the Board and Chief Executive Officer of VIVO. "Both Mr. Huber and Mr. Altman have... Read More

VIVO Cannabis Inc. ( TSX: VIVO) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced the launch of... Read More

VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today provided an update on... Read More

Net revenue $6.2 million Net loss reduced to $1.1 million; EBITDA loss reduced to $2.1 million First shipment to Germany completed; Australia sales $2.2 million VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO " or the " Company ") today released its third quarter 2021 financial and operating results. Management Commentary At the start of the third quarter of 2021, significant changes were made to focus VIVO's strategy... Read More

VIVO Cannabis Inc. ( TSX: VIVO) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced the launch of new products under its Lumina™ health and wellness brand. Lumina™ Ultralight 0:50 is a high... Read More

VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading medical cannabis company and holder of licenses under the Cannabis Act through its wholly owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann Medicinals"), today announced that its EU-GMP licensed subsidiary ABcann Medicinals has successfully completed its first shipment of EU-GMP certified... Read More

VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of premium cannabis products and services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced a partnership with Delta 9 Cannabis Inc ("Delta 9") to offer Delta 9 products on VIVO's Canna Farms... Read More

VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann Medicinals" or "ABcann"), today provides some additional information for its shareholders regarding the Company's future... Read More

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO " or the " Company ") today released its second quarter 2021 financial and operating results. Management Commentary "At the start of the third quarter of 2021, significant changes were made to the Board which subsequently has approved management's redefinition of the Company's strategy to fully leverage the efforts and investments that VIVO has made in the medical... Read More

VIVO Cannabis Inc. ( TSX: VIVO) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced the launch of Truro Cannabis products on VIVO's Canna Farms e-commerce marketplace . "The addition of Truro... Read More

VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced that its EU-GMP/GDP licensed subsidiary Beacon Medical Germany GmbH, has received its first import permit from... Read More

VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced the launch of Canna... Read More

VIVO Cannabis Inc. ( TSX: VIVO ) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders held today (the " Meeting "). As announced this morning, certain directors of the Company withdrew their nominations as directors prior to the Meeting, resulting in amendments to the... Read More

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO " or the " Company "), a leading provider of premium cannabis products and services, today announced that John Easson, Christie Henderson, Daryl Kramp and Rick Fitzgerald (whose temporary appointment as Interim Chief Executive Officer ended as of June 30, 2021) have resigned as directors of the Company, effective immediately, and have withdrawn their nominations to be... Read More

VIVO Cannabis Inc. ( TSX: VIVO) ( OTCQX: VVCIF ) (" VIVO " or the " Company "), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced the launch... Read More

Net revenue of $5.5 million – a decrease of 11% over Q4 2020 Vanluven facility received EU-GMP certification allowing VIVO to export cannabis products for sale in Europe and Beacon Medical Germany GmbH received an import license to allow imports of medical cannabis Released brick hash as part of VIVO's Cannabis 2.0 product... Read More

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO " or the " Company ") is pleased to announce the appointment of Ray Laflamme to the board of directors of the Company (the " Board "), effective as of April 12, 2021 . Mr. Laflamme joined VIVO in August 2018 , when it acquired Canna Farms Limited, a company co-founded by... Read More

Net revenue for Q4 2020 was $6.2 million ; Net revenue for 2020 was $32.8 million , an increase of over 32% compared with the same period last year Recorded first significant revenues from VIVO's Australian business in 2020 In October 2020 , began streamlining its Napanee, Ontario operations and integrating the operations of... Read More

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ( " VIVO " or the " Company ") today announced that the Company will release its fourth quarter 2020 results on Tuesday, March 30, 2021 , after the close of markets. VIVO also announced it will upload a quarterly results video following the release of its results in lieu of an... Read More

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (" VIVO " or the " Company ") today announced that its Vanluven facility in Napanee Ontario has received EU-GMP (European Union Good Manufacturing Practices) certification from Germany's Brandenburg health authority, the Landesamt für Arbeitsschutz, Verbraucherschutz und Gesundheit... Read More

VIVO Cannabis Inc. (TSX: VIVO) (" VIVO " or the " Company ") announced today the closing of its previously announced overnight marketed public offering (the " Offering ") of 38,333,334 units of the Company (each, a " Unit " and, collectively, the " Units ") for aggregate gross proceeds of approximately $8 million , including the full exercise of the over-allotment option granted to the underwriters in connection with the... Read More

VIVO or the " Company " is pleased to announce that it has commenced an overnight marketed public offering of units of the Company (each, a " Unit " and, collectively, the " Units ") at an issue price per Unit of $0.21 , for gross proceeds of approximately $7 million (the " Offering "). Each Unit will consist of one common share of the Company (each, a " Common Share ") and one half of one Common Share purchase warrant of... Read More